AVITA Medical, Inc. (RCEL) Cash Flow Statement

The lack of a consistent, positive relationship between net income and operating cash flow suggests that the business model has yet to achieve the scale necessary to decouple cash outflows from revenue generation. Investors should monitor this conversion gap, as it implies that the company's current accounting losses are a direct reflection of its underlying cash-consuming commercial strategy.

The trajectory of free cash flow remains deeply negative, suggesting that the company is currently in a high-intensity investment phase that shows little sign of near-term stabilization. This persistent cash drain warrants further investigation into whether the current sales force expansion will eventually yield the operating leverage required to reach cash flow breakeven.

These swings in working capital appear to reflect the challenges of managing a transactional, kit-based revenue model across a growing number of hospital accounts. The inconsistency in these flows may indicate that the company lacks a mature, predictable cycle for managing its receivables and inventory, adding another layer of uncertainty to its liquidity profile.